{"id":"W2138501761","doi":"10.1158/1078-0432.ccr-03-0463","title":"Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments","year":2004,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Metastatic breast cancer; Celecoxib; Breast cancer; Internal medicine; Oncology; Regimen; Rash; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001850332,0.001572209,0.002736707,0.0004738841,0.0005962629,0.001008352,0.0009174992,0.001611698,0.002996979],"category_scores_gemma":[0.001139479,0.0007269533,0.00114626,0.0004388378,0.00101457,0.0007055488,0.0004032512,0.003751851,0.0008065846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007959536,"about_ca_system_score_gemma":0.001892372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000844863,"about_ca_topic_score_gemma":0.001762394,"domain_scores_codex":[0.9993377,0.0003265094,0.00003149891,0.0000862165,0.00006876873,0.0001493562],"domain_scores_gemma":[0.9990947,0.0001196303,0.0001216667,0.0000770354,0.00006676994,0.0005200398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6458616,0.1955783,0.01322802,0.0006123125,0.001239912,0.0005832939,0.0003607822,0.002534293,0.05418788,0.000310719,0.003377286,0.08212563],"study_design_scores_gemma":[0.5009121,0.4823761,0.00961347,0.00002364902,0.0002286933,0.0002841154,0.00004333502,0.001015133,0.003229013,0.00009636601,0.002161869,0.00001616004],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918001,0.00173686,0.0005738836,0.0004446575,0.0001560172,0.003503672,0.0004723723,0.00005404308,0.00125836],"genre_scores_gemma":[0.9847178,0.001783291,0.001660876,0.001109175,0.0003359206,0.005557766,0.001889414,0.00002454487,0.002921202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002996979,"threshold_uncertainty_score":0.01002592,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1846703249882754,"score_gpt":0.5588671635938909,"score_spread":0.3741968386056155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}